Lincoln Pharma.

{
  "main_header": {
    "sid": 294056,
    "name": "Lincoln Pharma.",
    "stock_name": "Lincoln Pharma.",
    "full_name": "Lincoln Pharmaceuticals Ltd",
    "name_url": "stocks-analysis/lincoln-pharma",
    "exchange": 1,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "478.30",
    "chg": 13.3,
    "chgp": "2.86%",
    "dir": 1,
    "prev_price": "465.00",
    "mcapval": "970.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 531633,
    "symbol": "LINCOLN",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE405C01035",
    "curr_date": "Feb 03",
    "curr_time": "",
    "bse_nse_vol": "17.76 k",
    "exc_status": "Active",
    "traded_date": "Feb 03, 2026",
    "traded_date_str": "2026 02 03",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/lincoln-pharma-294056-1&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Why is Lincoln Pharmaceuticals Ltd falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-lincoln-pharmaceuticals-ltd-fallingrising-3819271",
        "imagepath": "",
        "date": "2026-02-04 01:07:03",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Recent Price Movement and Sector Influence</strong></p>\n<p>Lincoln Pharmaceuticals has been on a four-day winning streak, accumulating gains of 7.4% during this period. On the day in question, the stock opened with a gap up of 3.89%, signalling strong buying interest from the outset. Intraday, it reached a high of ₹496.25, marking a 6.55% increase from the previous close. This performance aligns closely with the Pharmaceuticals &amp; Drugs sector, which itself advanced by 2.78% on the same day, suggesting that broader sectoral strength is supporting the stock’s rise.</p>\n<p>However, the trading volume dynamics reveal some caution. The weighted average price indicates that more volume was traded near the lower end of the day’s price range, and delivery volumes on 02 Feb fell by 37.09% compare..."
      },
      {
        "title": "Lincoln Pharmaceuticals Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/lincoln-pharmaceuticals-ltd-is-rated-sell-3817715",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/LincolnPharmace_mojoScore_3817715.png",
        "date": "2026-02-03 10:14:03",
        "description": "Lincoln Pharmaceuticals Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 07 August 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 03 February 2026, providing investors with an up-to-date perspective on the company’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Lincoln Pharmaceuticals Ltd Falls to 52-Week Low of Rs.439.95",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/lincoln-pharmaceuticals-ltd-falls-to-52-week-low-of-rs43995-3807601",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/LincolnPharmace_priceRelatedfactors_3807601.png",
        "date": "2026-01-28 10:41:39",
        "description": "Lincoln Pharmaceuticals Ltd’s stock price declined to a fresh 52-week low of Rs.439.95 on 28 Jan 2026, marking a significant downturn amid broader market gains. The stock has underperformed its sector and benchmark indices, reflecting ongoing concerns about its recent financial performance and valuation metrics."
      },
      {
        "title": "Lincoln Pharmaceuticals Ltd Falls to 52-Week Low of Rs 442.85",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/lincoln-pharmaceuticals-ltd-falls-to-52-week-low-of-rs-44285-3806342",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/LincolnPharmace_priceRelatedfactors_3806342.png",
        "date": "2026-01-27 15:42:42",
        "description": "Lincoln Pharmaceuticals Ltd’s shares declined to a fresh 52-week low of Rs.442.85 on 27 Jan 2026, marking a significant milestone in the stock’s recent performance. The pharmaceutical company’s stock has been under pressure, reflecting a combination of subdued financial results and broader sector dynamics."
      },
      {
        "title": "Lincoln Pharmaceuticals Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/lincoln-pharmaceuticals-ltd-is-rated-sell-3801384",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/LincolnPharmace_mojoScore_3801384.png",
        "date": "2026-01-23 10:10:54",
        "description": "Lincoln Pharmaceuticals Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 07 August 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 23 January 2026, providing investors with an up-to-date view of the company's fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Lincoln Pharmaceuticals Ltd Falls to 52-Week Low of Rs.453.05",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/lincoln-pharmaceuticals-ltd-falls-to-52-week-low-of-rs45305-3798669",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/LincolnPharmace_priceRelatedfactors_3798669.png",
        "date": "2026-01-21 11:51:57",
        "description": "Lincoln Pharmaceuticals Ltd has touched a fresh 52-week low of Rs.453.05 today, marking a significant decline amid a sustained downward trajectory. The stock has underperformed its sector and broader market indices, reflecting ongoing pressures on its financial performance and market sentiment."
      },
      {
        "title": "Lincoln Pharmaceuticals Ltd Stock Falls to 52-Week Low of Rs.454.55",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/lincoln-pharmaceuticals-ltd-stock-falls-to-52-week-low-of-rs45455-3796075",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/LincolnPharmace_priceRelatedfactors_3796075.png",
        "date": "2026-01-20 10:24:21",
        "description": "Lincoln Pharmaceuticals Ltd’s shares declined to a fresh 52-week low of Rs.454.55 on 20 Jan 2026, marking a significant downturn amid broader market fluctuations and company-specific performance concerns."
      },
      {
        "title": "Lincoln Pharmaceuticals Ltd Falls to 52-Week Low of Rs.465.25",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/lincoln-pharmaceuticals-ltd-falls-to-52-week-low-of-rs46525-3794456",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/LincolnPharmace_priceRelatedfactors_3794456.png",
        "date": "2026-01-19 10:32:18",
        "description": "Lincoln Pharmaceuticals Ltd’s shares declined to a fresh 52-week low of Rs.465.25 on 19 Jan 2026, marking a significant downturn amid broader market weakness and company-specific performance concerns."
      },
      {
        "title": "Lincoln Pharmaceuticals Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/lincoln-pharmaceuticals-ltd-is-rated-sell-3789708",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/LincolnPharmace_mojoScore_3789708.png",
        "date": "2026-01-12 10:10:38",
        "description": "Lincoln Pharmaceuticals Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 07 August 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 12 January 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing."
      }
    ],
    "total": 939,
    "sid": "294056",
    "stock_news_url": "https://www.marketsmojo.com/news/lincoln-pharmaceuticals-294056"
  },
  "announcements": [
    {
      "details": "Lincoln Pharmaceuticals Limited has informed the Exchange regarding Board meeting held on December 07, 2019 for consider and approved draft scheme of amalgamation and withdrawal scheme approved by Board earlier",
      "source": "NSE",
      "caption": "Lincoln Pharmaceuticals Limited - Outcome of Board Meeting",
      "datetime": "09-Dec-2019"
    },
    {
      "details": "Lincoln Pharmaceuticals Limited has informed the Exchange regarding Board meeting held on November 14, 2019 for Considered and Approved Un-Audited Standalone and Consolidated Financial Results for the Quarter and Half Year Ended on September 30, 2019",
      "source": "NSE",
      "caption": "Lincoln Pharmaceuticals Limited - Outcome of Board Meeting",
      "datetime": "14-Nov-2019"
    },
    {
      "details": "Lincoln Pharmaceuticals Limited has informed the Exchange regarding a press release dated October 22, 2019, titled \"press release dated October 22, 2019 titled \"Lincoln Pharmaceuticals Limited receives a Patent for Diclofenac Rectal Spray. \".",
      "source": "NSE",
      "caption": "Lincoln Pharmaceuticals Limited - Press Release",
      "datetime": "22-Oct-2019"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Lincoln Pharmaceuticals Ltd has declared <strong>18%</strong> dividend, ex-date: 12 Sep 25",
          "dt": "2025-09-12",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Lincoln Pharmaceuticals Ltd has announced <strong>10:2</strong> stock split, ex-date: 19 Mar 09",
          "dt": "2009-03-19",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Why is Lincoln Pharmaceuticals Ltd falling/rising?

2026-02-04 01:07:03

Recent Price Movement and Sector Influence

Lincoln Pharmaceuticals has been on a four-day winning streak, accumulating gains of 7.4% during this period. On the day in question, the stock opened with a gap up of 3.89%, signalling strong buying interest from the outset. Intraday, it reached a high of ₹496.25, marking a 6.55% increase from the previous close. This performance aligns closely with the Pharmaceuticals & Drugs sector, which itself advanced by 2.78% on the same day, suggesting that broader sectoral strength is supporting the stock’s rise.

However, the trading volume dynamics reveal some caution. The weighted average price indicates that more volume was traded near the lower end of the day’s price range, and delivery volumes on 02 Feb fell by 37.09% compare...

Read full news article

Lincoln Pharmaceuticals Ltd is Rated Sell

2026-02-03 10:14:03

Lincoln Pharmaceuticals Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 07 August 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 03 February 2026, providing investors with an up-to-date perspective on the company’s fundamentals, valuation, financial trends, and technical outlook.

Read full news article

Lincoln Pharmaceuticals Ltd Falls to 52-Week Low of Rs.439.95

2026-01-28 10:41:39

Lincoln Pharmaceuticals Ltd’s stock price declined to a fresh 52-week low of Rs.439.95 on 28 Jan 2026, marking a significant downturn amid broader market gains. The stock has underperformed its sector and benchmark indices, reflecting ongoing concerns about its recent financial performance and valuation metrics.

Read full news article

Lincoln Pharmaceuticals Ltd Falls to 52-Week Low of Rs 442.85

2026-01-27 15:42:42

Lincoln Pharmaceuticals Ltd’s shares declined to a fresh 52-week low of Rs.442.85 on 27 Jan 2026, marking a significant milestone in the stock’s recent performance. The pharmaceutical company’s stock has been under pressure, reflecting a combination of subdued financial results and broader sector dynamics.

Read full news article

Lincoln Pharmaceuticals Ltd is Rated Sell

2026-01-23 10:10:54

Lincoln Pharmaceuticals Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 07 August 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 23 January 2026, providing investors with an up-to-date view of the company's fundamentals, valuation, financial trends, and technical outlook.

Read full news article

Lincoln Pharmaceuticals Ltd Falls to 52-Week Low of Rs.453.05

2026-01-21 11:51:57

Lincoln Pharmaceuticals Ltd has touched a fresh 52-week low of Rs.453.05 today, marking a significant decline amid a sustained downward trajectory. The stock has underperformed its sector and broader market indices, reflecting ongoing pressures on its financial performance and market sentiment.

Read full news article

Lincoln Pharmaceuticals Ltd Stock Falls to 52-Week Low of Rs.454.55

2026-01-20 10:24:21

Lincoln Pharmaceuticals Ltd’s shares declined to a fresh 52-week low of Rs.454.55 on 20 Jan 2026, marking a significant downturn amid broader market fluctuations and company-specific performance concerns.

Read full news article

Lincoln Pharmaceuticals Ltd Falls to 52-Week Low of Rs.465.25

2026-01-19 10:32:18

Lincoln Pharmaceuticals Ltd’s shares declined to a fresh 52-week low of Rs.465.25 on 19 Jan 2026, marking a significant downturn amid broader market weakness and company-specific performance concerns.

Read full news article

Lincoln Pharmaceuticals Ltd is Rated Sell

2026-01-12 10:10:38

Lincoln Pharmaceuticals Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 07 August 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 12 January 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing.

Read full news article

View All News